Invitrogen Corporation (NASDAQ:IVGN), a provider of essential life science technologies for research, production and diagnostics, today announced the appointment of Joe Beery as head of Invitrogen’s Global Information Technology, effective September 8, 2008.

“In today’s competitive research environment, success depends upon real-time access to scientific tools and information,” said Greg Lucier, Chairman and Chief Executive Officer. “Invitrogen’s information technology enables customers to more easily make purchases on-line and have access to the latest information that makes their research faster and more reliable. Joe Beery will build upon the solid IT foundation we have in place, and will be instrumental in integrating Invitrogen and Applied Biosystems technologies to give our customers access to an even greater breadth of products and solutions.”

Beery brings to Invitrogen a 25-year background in IT strategy and implementation, having worked in all aspects of IT including complex merger and acquisition integrations, application development and support, IT infrastructure, and process engineering.

Most recently, Beery served as US Airways’ senior vice president and chief information officer, responsible for all IT business and operational systems and applications, process improvements, revenue generation and customer service programs. Prior to US Airways’ merger with America West, Beery served as America West’s CIO, and was responsible for integrating legacy US Airways systems and infrastructure into America West’s model. Prior to his tenure at US Airways/America West, Beery served multiple roles at Motorola Semiconductor and NV Philips.

“Over the coming months, the IT team will focus on the Invitrogen and Applied Biosystems integration,” said Beery. “We plan to deliver our new web ordering and customer relationship management systems, and data center consolidations in 2009, while also planning for ERP implementations in Asia-Pacific.”

Beery holds a bachelor’s degree in business administration and business computer systems from the University of New Mexico.

About Invitrogen

Invitrogen Corporation (NASDAQ:IVGN) provides products and services that support academic and government research institutions and pharmaceutical and biotech companies worldwide in their efforts to improve the human condition. The company provides essential life science technologies for disease research, drug discovery, and commercial bioproduction. Invitrogen’s own research and development efforts are focused on breakthrough innovation in all major areas of biological discovery including functional genomics, proteomics, stem cells, cell therapy and cell biology — placing Invitrogen’s products in nearly every major laboratory in the world. Founded in 1987, Invitrogen is headquartered in Carlsbad, California, and conducts business in more than 70 countries around the world. The company employs approximately 4,700 scientists and other professionals and had revenues of approximately $1.3 billion in 2007. For more information, visit www.invitrogen.com.

Safe Harbor Statement

Certain statements contained in this press release are considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is Invitrogen’s intent that such statements be protected by the safe harbor created thereby. Forward looking statements include, but are not limited to; 1) Over the coming months, the IT team will focus on the Invitrogen and Applied Biosystems integration; 2) The IT team plans to deliver our new web ordering and customer relationship management systems, and data center consolidations in 2009, while also planning for ERP implementations in Asia-Pacific. Potential risks and uncertainties include, but are not limited to the risks that the market will not accept the companies’ products and services, or that the companies will be unsuccessful in their efforts to develop new products and services, as well as other risks and uncertainties detailed from time to time in Invitrogen’s Securities and Exchange Commission filings.